期刊文献+

疏风解毒胶囊防治流感体内药效学实验研究 被引量:38

Study on Pharmacodynamic Trial in Vivo of Shufengjiedu Capsule on Prevention and Treatment of Influenza
下载PDF
导出
摘要 目的评价疏风解毒胶囊在体内对H1N1流感病毒感染的防治作用。方法本研究中采用甲型H1N1流感病毒FM1和PR8株滴鼻感染正常小鼠造成肺炎模型,分别进行治疗性和预防性给药,观察小鼠肺指数、病死率。结果①感染当天开始给予疏风解毒胶囊治疗,连续4 d后3个剂量组肺指数均明显降低;②预防性给予疏风解毒胶囊连续4 d,对两种病毒感染正常小鼠引起的肺部炎症有明显预防作用。③感染前预防性给予疏风解毒胶囊4 d,FM1株三个剂量组动物的死亡数均显著降低。结论疏风解毒胶囊可改善流感病毒引起的小鼠肺炎症状,降低H1N1感染小鼠的肺指数,对病毒性感冒有较好的治疗和预防作用;并可明显降低感染动物的死亡率,延长评价存活天数。 Objective To evaluate the action of shufengjiedu capsule on the prevention and treatment of the infection of H1 N1. Methods Normal mice were infected by nasal drop of FM1 and PR8 of A H1N1 to prepare the models of pneumonia. The medications for treatment and prevention were administered respectively. Pulmonary index and death rate were observed in mice. Results (1)Shufengjiedu capsule was administered light on the day of infection, continuously for 4 days. Afterwards, it was discovered that pulmonary index of all of three dose groups decreased apparently. (2) Shufengjiedu capsule was administered preventively and continuously for 4 days. It was discovered that the capsule presented apparent prevention on puhnonary inflammation induced by two kinds of virus in normal mice. (3)Shufengjiedu capsule was administered preventively before infection for 4 days continuously. It was discovered that the death rate of three dose groups of FM1 decreased significantly. Conclusion Shufengjiedu capsule can relieve pneumonia symptoms of mice induced by influenza virus, reduce pulmonary index in H1N1 infected mice and present good actions on the treatment and prevention of viral common cold. Additionally, it can decrease death rate of infected animal apparently and prolong the survival days in evaluation.
出处 《世界中西医结合杂志》 2010年第1期35-36,39,共3页 World Journal of Integrated Traditional and Western Medicine
基金 北京市科技计划 科技部科技计划--防治甲型H1N1流感专项
  • 相关文献

参考文献9

二级参考文献15

  • 1林江涛,于学忠,崔德健,陈旭岩,朱继红,王玉珍,吴霄迪,高和,霍正禄,朱顺和,胡善联,王爱霞.磷酸奥司他韦治疗高危人群流行性感冒患者多中心临床随机对照研究[J].中华结核和呼吸杂志,2004,27(7):455-459. 被引量:24
  • 2胡善联,林江涛,于学忠,王爱霞,朱继红,崔德健,陈旭岩,王玉珍,吴霄迪,高和,霍正禄,朱顺和.磷酸奥司他韦治疗流行性感冒的成本效果分析[J].中华医学杂志,2004,84(19):1664-1667. 被引量:10
  • 3陈奇,中药药理研究方法学,1993年
  • 4贺双滕,湖南中医学院学报,1991年,11卷,4期,55页
  • 5马淑清,黑龙江中医学院学报,1990年,1卷,22页
  • 6Dr. Scott Weingarten MD,Howard Staniloff MD,Mark Ault MD,Peggy Miles MD,Mark Bamberger MD,Richard D. Meyer MD. Do hospital employees benefit from the influenza vaccine?[J] 1988,Journal of General Internal Medicine(1):32~37
  • 7Monto AS,Fleming DM,Henry D,et al.Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections[].The Journal of Infectious Diseases.1999
  • 8McNicholl IR,McNicholl JJ.Neuraminidase inhibitors: zanamivir and oseltamivir[].Annals of Pharmacotherapy.2001
  • 9Hayden FG,Atmar RL,Schilling M,et al.Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza[].The New England Journal of Medicine.1999
  • 10Nicholson KG,Aoki FY,Osterhaus AD,et al.Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlledtrial.Neuraminidase Inhibitor Flu Treatment Investigator Group[].The Lancet.2000

共引文献173

同被引文献390

引证文献38

二级引证文献521

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部